Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00341809 · ClinicalTrials.gov registry record

Genetic Analysis of Psoriasis and Psoriatic Arthritis

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
2,653
Enrollment target

NCT00341809: Completed study, sponsored by National Cancer Institute (NCI).

NCT00341809 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 2,653 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00341809 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
2,653 participants
Enrollment target

Study Summary

This study will examine the genetic basis of psoriasis and psoriatic arthritis. It is known that genes play an important role in determining who gets psoriasis or psoriatic arthritis. This study will look for specific gene variants (alleles) that run in families with these conditions, or are found more often in people with these conditions than in those without them. Participants for this study were identified through the dermatology services of the University of Michigan Medical Center, the Ann Arbor Veterans Affairs Medical Center, the University of Kiel, and Henry Ford Hospital. Additional families were provided by the National Psoriasis Foundation Tissue Bank. They include people with psoriasis or psoriatic arthritis, or both, in addition to some family members of patients. Only families in which the age of the patient at disease onset was below 40 years are included. Patients were included if they had lesions covering more than 1 percent of their total body surface area or if at least two skin, scalp, nail, or joint lesions were diagnosed as psoriasis. Healthy volunteers are also enrolled as control subjects. Participants undergo the following procedures, as follows: Patients with psoriasis and people without psoriasis who have multiple family members with the disease * Skin evaluation * Photographs of lesions for documentation Patients with psoriatic arthritis and people without psoriatic arthritis who have multiple family members with the disease * Joint evaluation and possibly ultrasound * Joint X-rays or review of existing X-rays Patients with psoriasis only, with psoriatic arthritis, and healthy volunteers * Blood draw of 30 milliliters. Some of the blood collected will be used to test for rheumatoid factor and C-reactive protein in patients with psoriatic arthritis. * Periodic questionnaires to update health status information

Trial Details

FieldValue
Enrollment Target 2,653 participants
Start Date 2004-07-30
Est. Completion 2012-09-04

Sponsor

National Cancer Institute (NCI)

3,257 total trials

What the Registry Record Tells You About NCT00341809

The ClinicalTrials.gov registry entry for NCT00341809 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,653 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00341809 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00341809 about?

NCT00341809 is a clinical study titled "Genetic Analysis of Psoriasis and Psoriatic Arthritis". This study will examine the genetic basis of psoriasis and psoriatic arthritis. It is known that genes play an important role in determining who gets psoriasis or psoriatic arthritis. This study will look for specific gene variants (alleles) that run in families with these conditions, or are found m...

What is the current status of trial NCT00341809?

This trial is currently completed. The enrollment target is 2,653 participants. The study started on 2004-07-30. Estimated completion is 2012-09-04.

Who is sponsoring clinical trial NCT00341809?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.